TY - JOUR
T1 - Selective Decline of Intact HIV Reservoirs During the First Decade of ART Followed by Stabilization in Memory T Cell Subsets
AU - Nühn, Marieke M.
AU - Bosman, Kobus
AU - Huisman, Terry
AU - Staring, Wouter H.A.
AU - Gharu, Lavina
AU - Jong, Dorien D.E.
AU - de Kort, Theun M.
AU - Buchholtz, Ninée V.E.J.
AU - Tesselaar, Kiki
AU - Pandit, Aridaman
AU - Arends, Joop
AU - Otto, Sigrid A.
AU - Esesarte, Eduardo LUCIO D.E.
AU - Hoepelman, Andy I.M.
AU - de Boer, Rob J.
AU - Symons, Jori
AU - Borghans, José A.M.
AU - Wensing, Annemarie M.J.
AU - Nijhuis, Monique
N1 - Publisher Copyright:
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
PY - 2025/1/1
Y1 - 2025/1/1
N2 - Objectives: To investigate the short- and long-term dynamics of intact and defective proviral HIV DNA during ART. Design: We evaluated viral reservoir dynamics in a cohort of nine individuals with chronic HIV-1 subtype B infection who initiated first-line ART and were followed for 20 years while continuing ART. Methods: PBMCs were obtained before ART (n=5), during the first year, and after 8.5 and 20 years of treatment. T cell subsets (naive, central-memory, transitional-memory and effector-memory) were sorted at 8.5 and 20 years. DNA was isolated and analyzed using the intact proviral DNA assay (IPDA). Deep-sequencing of the viral env region enabled analysis of viral evolution and cellular mechanisms underlying HIV persistence. Results: Initially, defective and intact proviral DNA in PBMCs declined with half-lives of 3.6 and 5.4 weeks, respectively. Over the following 8.5 years, the intact reservoir continued to decrease, with a half-life of 18.8 months in PBMCs, while defective proviral DNA levels stabilized. After 8.5 and 20 years of ART, the intact reservoir showed no further decline, with most intact proviral DNA residing in memory T cell subsets. Phylogenetic analysis revealed no signs of viral evolution over time, both within and between T cell subsets. Conclusions: PBMCs containing intact proviral DNA are selectively lost during the first decade of suppressive ART, followed by a decade of stabilization of this reservoir in the memory T cell subsets. In the absence of clear signs of viral evolution and massive clonal expansion, homeostatic proliferation might be an important driver of HIV persistence during long-term ART.
AB - Objectives: To investigate the short- and long-term dynamics of intact and defective proviral HIV DNA during ART. Design: We evaluated viral reservoir dynamics in a cohort of nine individuals with chronic HIV-1 subtype B infection who initiated first-line ART and were followed for 20 years while continuing ART. Methods: PBMCs were obtained before ART (n=5), during the first year, and after 8.5 and 20 years of treatment. T cell subsets (naive, central-memory, transitional-memory and effector-memory) were sorted at 8.5 and 20 years. DNA was isolated and analyzed using the intact proviral DNA assay (IPDA). Deep-sequencing of the viral env region enabled analysis of viral evolution and cellular mechanisms underlying HIV persistence. Results: Initially, defective and intact proviral DNA in PBMCs declined with half-lives of 3.6 and 5.4 weeks, respectively. Over the following 8.5 years, the intact reservoir continued to decrease, with a half-life of 18.8 months in PBMCs, while defective proviral DNA levels stabilized. After 8.5 and 20 years of ART, the intact reservoir showed no further decline, with most intact proviral DNA residing in memory T cell subsets. Phylogenetic analysis revealed no signs of viral evolution over time, both within and between T cell subsets. Conclusions: PBMCs containing intact proviral DNA are selectively lost during the first decade of suppressive ART, followed by a decade of stabilization of this reservoir in the memory T cell subsets. In the absence of clear signs of viral evolution and massive clonal expansion, homeostatic proliferation might be an important driver of HIV persistence during long-term ART.
KW - antiretroviral therapy
KW - defective
KW - HIV
KW - intact
KW - persistence
KW - reservoir dynamics
KW - T cell subsets
U2 - 10.1097/QAD.0000000000004160
DO - 10.1097/QAD.0000000000004160
M3 - Article
SN - 0269-9370
JO - Aids
JF - Aids
ER -